Optibiotix Health Plc (LON:OPTI) is one of the companies that will gain more awareness after the governments advisory group Public Health England saw it’s recent report leaked. The report highlights a number of policies that need to be taken in order to promote a healthier UK and reduce a £5.1bn strain on the NHS. You can find the full key points from the report on the Guardians website: http://www.theguardian.com/society/2015/oct/22/public-health-england-obesity-report-key-points
OptiBiotix’s CEO Stephen OHara said ‘This report from Public Health England recommending restrictions on advertising and a tax on high sugar foods and drinks reflects growing public and political concern towards traditional sugars and their impact on public health. OptiBiotix is developing non digestible natural healthy sugars with zero calories. As companies become aware of our development programs we are finding increasing interest from food and drink manufacturers looking to incorporate ‘healthy sugars’ into their foods as the link between what we eat and health becomes more widely known’
The aim of OptiBiotix Health Plc is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
